1. Home
  2. TTC vs QGEN Comparison

TTC vs QGEN Comparison

Compare TTC & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$92.72

Market Cap

9.3B

ML Signal

HOLD

Logo Qiagen N.V.

QGEN

Qiagen N.V.

HOLD

Current Price

$40.53

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
QGEN
Founded
1914
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
10.2B
IPO Year
1994
1998

Fundamental Metrics

Financial Performance
Metric
TTC
QGEN
Price
$92.72
$40.53
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$104.00
$51.30
AVG Volume (30 Days)
908.3K
1.8M
Earning Date
03-05-2026
05-06-2026
Dividend Yield
1.67%
5.97%
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$2,618,650,000.00
N/A
Revenue This Year
$6.11
$8.18
Revenue Next Year
$4.45
$5.66
P/E Ratio
$135.43
$24.01
Revenue Growth
4.53
N/A
52 Week Low
$62.34
$38.13
52 Week High
$105.19
$57.82

Technical Indicators

Market Signals
Indicator
TTC
QGEN
Relative Strength Index (RSI) 42.06 38.09
Support Level $91.80 N/A
Resistance Level $96.79 $48.60
Average True Range (ATR) 2.45 0.85
MACD -0.30 0.29
Stochastic Oscillator 33.20 62.75

Price Performance

Historical Comparison
TTC
QGEN

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: